Literature DB >> 19467850

Clinical significance of isolation of nontuberculous mycobacteria in pulmonary tuberculosis patients.

Chun-Ta Huang1, Yi-Ju Tsai, Chin-Chung Shu, Yung-Chao Lei, Jann-Yuan Wang, Chong-Jen Yu, Li-Na Lee, Pan-Chyr Yang.   

Abstract

BACKGROUND: Clinical significance of isolation of nontuberculous mycobacteria (NTM) from respiratory specimens in patients with pulmonary tuberculosis is unknown. This study aimed to investigate the prevalence and clinical impact of NTM in pulmonary tuberculosis patients.
METHODS: We retrospectively reviewed data of patients with culture-confirmed pulmonary tuberculosis from 2000 to 2006. Those in whom NTM were isolated from respiratory specimens collected within two months before and nine months after the index culture of tuberculosis was plated were compared with those without NTM. Patients were followed for one year after initiation of anti-tuberculous treatment.
RESULTS: Among 2133 patients with pulmonary tuberculosis, 48 (2.3%) with multiple and 106 (5.0%) with one isolate(s) of NTM were identified. Another 144 without NTM were selected and compared. The one-year mortality rates were similar among three groups. Patients with multiple NTM isolates were more likely to be symptomatic, sought medical help earlier, had smear-positive respiratory specimens, and received anti-tuberculous treatment later than those with single/no isolate(s). Cavities were more commonly visualized radiographically in patients with multiple/single NTM isolate(s) than those without NTM isolates. The mean duration of anti-tuberculous treatment was 8.8 months for patients with multiple NTM isolates, significantly longer than that in patients with single (7.6 months) and no NTM isolate(s) (7.5 months).
CONCLUSIONS: NTM were present in the respiratory tract of 7.3% of patients with pulmonary tuberculosis. Although the outcomes were similar, the presence of NTM was associated with different clinical manifestations and had a significant impact on the treatment of tuberculosis.

Entities:  

Mesh:

Year:  2009        PMID: 19467850     DOI: 10.1016/j.rmed.2009.04.017

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  10 in total

1.  "Multidrug-resistant tuberculosis" may be nontuberculous mycobacteria.

Authors:  Abdolrazagh Hashemi Shahraki; Parvin Heidarieh; Saeed Zaker Bostanabad; Azar Dokht Khosravi; Mohammad Hashemzadeh; Solmaz Khandan; Maryam Biranvand; Dean E Schraufnagel; Mehdi Mirsaeidi
Journal:  Eur J Intern Med       Date:  2015-03-14       Impact factor: 4.487

2.  The significance of Mycobacterium abscessus subspecies abscessus isolation during Mycobacterium avium complex lung disease therapy.

Authors:  David E Griffith; Julie V Philley; Barbara A Brown-Elliott; Jeana L Benwill; Sara Shepherd; Deanna York; Richard J Wallace
Journal:  Chest       Date:  2015-05       Impact factor: 9.410

3.  Prevalence and associated risk factors of mycobacterial infections in slaughter pigs from Mubende district in Uganda.

Authors:  Adrian Muwonge; Clovice Kankya; Jacques Godfroid; Berit Djonne; John Opuda-Asibo; Demelash Biffa; Takele Ayanaw; Musso Munyeme; Eystein Skjerve
Journal:  Trop Anim Health Prod       Date:  2009-12-12       Impact factor: 1.559

4.  Predicting results of mycobacterial culture on sputum smear reversion after anti-tuberculous treatment: a case control study.

Authors:  Chin-Chung Shu; Jann-Tay Wang; Chih-Hsin Lee; Jann-Yuan Wang; Li-Na Lee; Chong-Jen Yu
Journal:  BMC Infect Dis       Date:  2010-03-06       Impact factor: 3.090

5.  Trends and predictors of changes in pulmonary function after treatment for pulmonary tuberculosis.

Authors:  Kuei-Pin Chung; Jung-Yueh Chen; Chih-Hsin Lee; Huey-Dong Wu; Jann-Yuan Wang; Li-Na Lee; Chong-Jen Yu; Pan-Chyr Yang
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

6.  Prevalence of nontuberculous mycobacteria among extrapulmonary tuberculosis cases in tertiary care centers in Northern India.

Authors:  A K Maurya; V L Nag; S Kant; R A S Kushwaha; M Kumar; A K Singh; T N Dhole
Journal:  Biomed Res Int       Date:  2015-03-26       Impact factor: 3.411

7.  Evaluation of GeneXpert MTB/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest Iran.

Authors:  S Atashi; B Izadi; S Jalilian; S H Madani; A Farahani; P Mohajeri
Journal:  New Microbes New Infect       Date:  2017-07-13

8.  Distribution of nontuberculous Mycobacteria strains.

Authors:  Murat Gunaydin; Keramettin Yanik; Cafer Eroglu; Ahmet Sanic; Ismail Ceyhan; Zayre Erturan; Riza Durmaz
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-11-21       Impact factor: 3.944

9.  Clinical significance of smear positivity for acid-fast bacilli after ≥5 months of treatment in patients with drug-susceptible pulmonary tuberculosis.

Authors:  Hyung Koo Kang; Byeong-Ho Jeong; Hyun Lee; Hye Yun Park; Kyeongman Jeon; Hee Jae Huh; Chang-Seok Ki; Nam Yong Lee; Won-Jung Koh
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

10.  Changes in chest X-ray findings in 1- and 2-month group after treatment initiation for suspected pulmonary tuberculosis.

Authors:  Jang Ho Lee; Ock-Hwa Kim; Yeon Joo Kim; Tae Sun Shim; Kyung-Wook Jo
Journal:  Korean J Intern Med       Date:  2020-02-18       Impact factor: 2.884

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.